Introduction 51
The interest in measuring biological markers in exhaled breath condensate (EBC) in 52
Respiratory phenotypes 98
Subjects with ever asthma were defined by a positive answer to either: "Have you ever had 99 attacks of breathlessness at rest with wheezing?", or "Have you ever had asthma attacks?", or 100 if they were recruited as asthmatic cases at the first survey. 101
Allergic sensitization was defined by a positive skin prick test (SPT+) with a mean wheal 102 diameter 3mm than the negative control for at least one of 12 aeroallergens (indoor: cat, 103
Dermatophagoides pteronyssinus, Blattela germanica, outdoor: olive, birch, Parieteria 104 judaica, timothy grass, Cupressus and ragweed pollen, and molds: Aspergillus, Cladosporium 105 herbarum, Alternaria tenuis). Subjects were classified as sensitized if they have one or more 106 SPT+. Current rhinitis was defined by a positive answer to one of the two questions: "Have 107 you ever had rhinitis?" or " Have you ever had hay fever?" and a positive answer to "have 108 you had sneezing problems or a runny nose in the past 12 months?" Allergic rhinitis was 109 defined as having both current rhinitis and one or more SPT+. Subjects were also classified in 110 three groups as non sensitized (no SPT+), sensitized only (having one or more SPT+ and no 111 current rhinitis) and as having allergic rhinitis (one or more SPT+ and current rhinitis). 112
Eosinophilia was defined as eosinophil count ≥5%. Details on other phenotypes are given in 113 supplementary data. 114
115

Biological phenotypes 116
Exhaled breath condensate (EBC) was collected with an RTube™ according a standardized 117 method. Briefly, the RTube (TM) was rinsed with deionized water and dried thoroughly. 118
Participants breathed orally at tidal volumes into a mouthpiece attached to a cold condenser (-119 20°C). They were seated comfortably with a headrest. All headrests and back seats were tilted 120 slightly to avoid any saliva contamination during breathing maneuvers (see supplementary 121 data for more details). 122
Total nitrite-nitrate (NO 2 − /NO 3 − ) levels were measured in plasma and EBC as previously 123 described [24] . All measurements were done in duplicate. Analytical intra-run imprecision 124 was below 3%. Measurements with a coefficient of variation >15% and extreme outliers 125 (n=7) were excluded from the analyses (see supplementary data for more details). 126
Measurements of FE NO were realized before other pulmonary function tests according to 127
ATS/ERS recommendations (see supplementary data). The measurement was performed only 128
in 3 of the 5 centers involved in the EGEA study, which explained in a large part the attrition 129 on numbers of subjects included in the analysis compared to the total number. FE NO level was 130 measured at 50mL/s flow rate as previously described [23] . 131
132
Statistical Methods 133
Joint distribution of asthma, SPT+ and current rhinitis was shown with a Venn diagram 134 (Figure 1 with linear regression models. Parameter estimates were assessed by using generalized 155 estimating equations, with an exchangeable working correlation to account for the potential 156 clustering within families (SAS MIXED procedure). The level of statistical significance was 157 set at α=0.05. Two-sided P values were reported for all association estimates. All analyses 158
were conducted using SAS software, version 9.3 (SAS Institute, Inc., Cary, NC, USA). 159
160
Results
161
The characteristics of the 523 adults according to their asthma status are summarized in Table  162 1. As expected, subjects with asthma had significantly higher eosinophilia, lower FEV 1 % 163 predicted, more often bronchial hyper-responsiveness (BHR), SPT+, and reported more often 164 current rhinitis than subjects without asthma. After adjustment for age, sex and smoking, the 165 following associations between asthma and eosinophilia (odds ratio (OR) 3.12, 95% 166 confidence interval (CI, 1.72-5.66), FEV 1 % predicted (mean ± SD: 107.7 ± 10.5 vs. 97. Table 4 ). In a model adjusted for covariates, including asthma, EBC 194 1 in supplementary data), and when subjects were classified in the following groups: no 198 SPT+, SPT+ only, and both SPT+ and current rhinitis (see Table 4 and Figure 2 (Table 4) , and gradually increased with SPTQ (see Figure online for 208 details), and with allergic sensitization and current rhinitis. FE NO was also significantly and 209 positively associated with current rhinitis. The associations between FE NO levels and SPT+, 210 and current rhinitis were confirmed when BMI instead of height was added as covariate in the 211
models (data not shown). 212
No significant association were observed between the (NO 2 − + NO 3 − )/NO ratio (NOx/NO 213 ratio) and SPT+, current rhinitis or both (Table 4 and Figure 2 ). When analysing SPT+ to 214 indoor, outdoor or molds allergens separately, EBC NO 2 − /NO 3 − levels showed positive and 215 significant associations with sensitization to molds allergens, and FE NO levels were positively 216 associated to indoor allergens (Table 4) . 217
Discussion 219
The present study conducted on a large sample of adults with a precise phenotypic 220 characterization shows for the first time the similarities and differences for the associations of 221 both FE NO and exhaled breath condensate NO 2 − /NO 3 − levels with asthma, allergic 222 sensitization and rhinitis. Results showed higher EBC NO 2 − /NO 3 − and FE NO levels in subjects 223 with allergic sensitization, with current rhinitis, and in particular when both are present. Only 224 FE NO levels were found to be higher with asthma. EBC NO 2 − /NO 3 − and FE NO levels were 225 positively associated in sensitized subjects only, and EBC NO 2 − /NO 3 − levels were found to be 226 associated with allergic sensitization in subjects with higher FE NO levels only. 227
The selection of the 523 subjects included in the present analyses was driven first by the 228 random availability of the FE NO measurements in three of the five participating centres [23] , 229
and secondly by the availability of the other variables of interest. Definition of asthma case is 230 very precise in our study since asthmatic cases were recruited in chest clinics, and a procedure 231 was set up to include true asthmatics, leading to a very limited risk of false positives. 232
Prevalence of bronchial hyper-responsiveness, measured by a methacholine challenge test was 233 quite high in subjects without asthma. A possible explanation is that part of the subjects 234 without asthma are first degree relatives of asthma cases. Nevertheless, this result is 235 consistent with the relatively considerable number of asymptomatic subjects with BHR 236 reported in cross-sectional epidemiologic studies, ranging from 19.3 to 62.4%. Subjects 237 included in the analyses had higher EBC NO 2 − /NO 3 − and FE NO levels than non-selected 238 subjects. Other limitations of the present study were those commonly related to cross-239 sectional analyses of the data. 
286
+ S-nitrosothiols)/NO was found to better evaluate inflammation in a case-control study on 287 asthma [13] than the measurement of each oxide of nitrogen alone. This discrepancy in the 288 results may be partly explained by the lack of measurement of S-nitrosothiols in our study, by 289 the fact that we studied allergic sensitization rather than inflammation, and/or by differences 290 in study designs. 291
Overall, even if our results need to be replicated, they may suggest a role of the nitrate-nitrite-292 NO pathway in allergic sensitization. We suggest that exposure to allergens results in uptake 293 tissues [35, 36] . Moreover, NO modulates the Th1/Th2 balance by favoring Th2 response and 312
IL-5 production and thus recruiting eosinophils into the airways. Nevertheless, even if EBC 313
NO 2 − /NO 3 − level can be viewed as a potential biological marker of allergy in our study, its 314 specific role remains unknown, and mechanistic studies are required. As suggested through 315 the results of the present study, and as reported by Erzurum et al. [37] , the complexity of the 316 nitrate-nitrite-NO pathway provide evidence that more targeted biological markers are needed 317 to put them into a global scheme that help us to identify a type of response or phenotype for a 318 given patient, requiring the integration of multiple factors in a system biology approach. 319
Further studies are also warranted to better investigate the associations we observed in this 320 epidemiological study, and the potential for a practical utility of our findings. 321
In conclusion, we report for the first time in a large epidemiological study that both total 322 SPT+: a mean wheal diameter 3mm than the negative control for at least one of 12 aeroallergens. The symptomatic score is based on the number of asthma symptoms (wheeze and breathlessness, woken with chest tightness, woken by attack of shortness of breath, attack of shortness of breath at rest, attack of shortness of breath after exercise). *Methacholine challenge test was not performed if baseline FEV 1 <80% predicted. GM= geometric mean, Q1-Q3=first and third quartile. 
